{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:31:33Z","timestamp":1795008693111,"version":"4.9.1"},"reference-count":100,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Today, it is no longer a hypothesis, but an established fact, that increased plasma concentrations of cholesterol-rich apolipoprotein-B (apoB)-containing lipoproteins are causatively linked to atherosclerotic cardiovascular disease (ASCVD) and that lowering plasma LDL concentrations reduces cardiovascular events in humans. Here, we review evidence behind this assertion, with an emphasis on recent studies supporting the \u2018response-to-retention\u2019 model \u2013 namely, that the key initiating event in atherogenesis is the retention, or trapping, of cholesterol-rich apoB-containing lipoproteins within the arterial wall.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>New clinical trials have shown that ezetimibe and anti-PCSK9 antibodies \u2013 both nonstatins \u2013 lower ASCVD events, and they do so to the same extent as would be expected from comparable plasma LDL lowering by a statin. These studies demonstrate beyond any doubt the causal role of apoB-containing lipoproteins in atherogenesis. In addition, recent laboratory experimentation and human Mendelian randomization studies have revealed novel information about the critical role of apoB-containing lipoproteins in atherogenesis. New information has also emerged on mechanisms for the accumulation in plasma of harmful cholesterol-rich and triglyceride-rich apoB-containing remnant lipoproteins in states of overnutrition. Like LDL, these harmful cholesterol-rich and triglyceride-rich apoB-containing remnant lipoprotein remnants become retained and modified within the arterial wall, causing atherosclerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>LDL and other cholesterol-rich, apoB-containing lipoproteins, once they become retained and modified within the arterial wall, cause atherosclerosis. This simple, robust pathophysiologic understanding may finally allow us to eradicate ASCVD, the leading killer in the world.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mol.0000000000000330","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T12:59:29Z","timestamp":1470747569000},"page":"473-483","source":"Crossref","is-referenced-by-count":492,"title":["The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity"],"prefix":"10.1097","volume":"27","author":[{"given":"Jan","family":"Bor\u00e9n","sequence":"first","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg"},{"name":"Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Jon","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg"},{"name":"Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"Section of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1161\/ATVBAHA.115.306442","article-title":"Nonstatin low-density lipoprotein\u2014lowering therapy and cardiovascular risk reduction\u2014statement from ATVB Council","volume":"35","author":"Hegele","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R6-20230917","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/CIRCRESAHA.115.307609","article-title":"How an artery heals","volume":"117","author":"Williams","year":"2015","journal-title":"Circ Res"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1194\/jlr.R400003-JLR200","article-title":"Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: Part I","volume":"45","author":"Steinberg","year":"2004","journal-title":"J Lipid Res"},{"key":"R8-20230917","first-page":"631","article-title":"Pathogenie de l\u2019atherosclerose: mises \u00e0 jour des trois theories dominantes","volume":"38","author":"Capron","year":"1989","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/clc.4960230717","article-title":"Profiles in cardiology. Rudolph Virchow and cellular pathology","volume":"23","author":"Ventura","year":"2000","journal-title":"Clin Cardiol"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.ATV.0000174795.62387.d3","article-title":"Lipoprotein retention \u2013 and clues for atheroma regression","volume":"25","author":"Williams","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R12-20230917","first-page":"1","article-title":"\u00dcber experimentelle Cholesterinsteatose und ihre Bedeutung f\u00fcr die Entstehung einiger pathologischer Prozesse","volume":"24","author":"Anitschkow","year":"1913","journal-title":"Zentrbl Allg Pathol Pathol Anat"},{"key":"R13-20230917","first-page":"417","article-title":"Anichkov and his theory of atherosclerosis","volume":"33","author":"Konstantinov","year":"2006","journal-title":"Tex Heart Inst J"},{"key":"R14-20230917","first-page":"342","article-title":"The human aorta; sulfate-containing polyuronides and the deposition of cholesterol","volume":"48","author":"Faber","year":"1949","journal-title":"Arch Pathol (Chic)"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0021-9150(75)90095-7","article-title":"The participation of aortic proteins in the formation of complexes between low density lipoproteins and intima-media extracts","volume":"21","author":"Camejo","year":"1975","journal-title":"Atherosclerosis"},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0021-9258(19)45469-0","article-title":"The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans","volume":"247","author":"Iverius","year":"1972","journal-title":"J Biol Chem"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"8234","DOI":"10.1016\/S0021-9258(18)43414-X","article-title":"Interaction of serum lipoproteins and a proteoglycan from bovine aorta","volume":"256","author":"Vijayagopal","year":"1981","journal-title":"J Biol Chem"},{"key":"R18-20230917","first-page":"39","article-title":"Lipids and low density lipoproteins in intima in relation to its morphological characteristics","volume":"12","author":"Smith","year":"1973","journal-title":"Ciba Found Symp"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.ATV.19.4.847","article-title":"Ultrastructure of early lipid accumulation in ApoE-deficient mice","volume":"19","author":"Tamminen","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/01.ATV.9.6.908","article-title":"Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries","volume":"9","author":"Schwenke","year":"1989","journal-title":"Arteriosclerosis"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/ATVBAHA.106.134080","article-title":"Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration","volume":"27","author":"Nakashima","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00041433-200010000-00002","article-title":"Role of extracellular retention of low density lipoproteins in atherosclerosis","volume":"11","author":"Bor\u00e9n","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-2275(20)38701-0","article-title":"Interstitial fluid lipoproteins","volume":"28","author":"Sloop","year":"1987","journal-title":"J Lipid Res"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"C242","DOI":"10.1152\/ajpcell.00185.2008","article-title":"Role of caveolin-1 in the regulation of lipoprotein metabolism","volume":"295","author":"Frank","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"R25-20230917","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cmet.2009.06.003","article-title":"Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis","volume":"10","author":"Fern\u00e1ndez-Hernando","year":"2009","journal-title":"Cell Metab"},{"key":"R26-20230917","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cvr\/cvv218","article-title":"A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis","volume":"108","author":"Armstrong","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"(Suppl 1)","key":"R27-20230917","first-page":"S12","article-title":"Identification of novel mechanisms of LDL uptake into endothelium","volume":"387","author":"Kraehling","year":"2014","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1172\/JCI118824","article-title":"Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta","volume":"98","author":"Nielsen","year":"1996","journal-title":"J Clin Invest"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.ATV.17.5.905","article-title":"In vivo transfer of lipoprotein(a) into human atherosclerotic carotid arterial intima","volume":"17","author":"Nielsen","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIRCRESAHA.115.307182","article-title":"Altered metabolism of LDL in the arterial wall precedes atherosclerosis regression","volume":"117","author":"Bartels","year":"2015","journal-title":"Circ Res"},{"key":"R31-20230917","first-page":"43","article-title":"Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation","volume":"103","author":"Tran-Lundmark","year":"2008","journal-title":"Circ Res"},{"key":"R32-20230917","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1172\/JCI2265","article-title":"Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding","volume":"101","author":"Bor\u00e9n","year":"1998","journal-title":"J Clin Invest"},{"key":"R33-20230917","doi-asserted-by":"crossref","first-page":"32228","DOI":"10.1074\/jbc.M204053200","article-title":"Identification of the proteoglycan binding site in apolipoprotein B48","volume":"277","author":"Flood","year":"2002","journal-title":"J Biol Chem"},{"key":"R34-20230917","doi-asserted-by":"crossref","first-page":"14131","DOI":"10.1016\/S0021-9258(19)85218-3","article-title":"Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells","volume":"268","author":"Camejo","year":"1993","journal-title":"J Biol Chem"},{"key":"R35-20230917","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2013.12.049","article-title":"Proteoglycan-LDL interactions: a novel therapeutic target?","volume":"233","author":"Tannock","year":"2014","journal-title":"Atherosclerosis"},{"key":"R36-20230917","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis","volume":"417","author":"Sk\u00e5l\u00e9n","year":"2002","journal-title":"Nature"},{"key":"R37-20230917","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1194\/jlr.M400019-JLR200","article-title":"Atherosclerosis in perlecan heterozygous mice","volume":"45","author":"Vikramadithyan","year":"2004","journal-title":"J Lipid Res"},{"key":"R38-20230917","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1194\/jlr.M700329-JLR200","article-title":"Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development","volume":"49","author":"Huang","year":"2008","journal-title":"J Lipid Res"},{"key":"R39-20230917","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1194\/jlr.P040139","article-title":"Prevention of TGF\u00df induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr \u2212\/\u2212 mice","volume":"54","author":"Tang","year":"2013","journal-title":"J Lipid Res"},{"key":"R40-20230917","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/ATVBAHA.115.306074","article-title":"NG2 ablation reduces low-density lipoprotein retention of synthetic smooth muscle cells and atherogenesis","volume":"36","author":"She","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R41-20230917","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/ATVBAHA.115.306798","article-title":"Catch and release: NG2-coated vascular smooth muscle cells capture lipoproteins for macrophages","volume":"36","author":"Fogelstrand","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R42-20230917","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/01.ATV.0000257133.60884.44","article-title":"Group V secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice","volume":"27","author":"Bostrom","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R43-20230917","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.ATV.0000258412.58289.ee","article-title":"PLA2-V: a real player in atherogenesis","volume":"27","author":"\u00d6\u00f6rni","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R44-20230917","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/CIRCRESAHA.107.149666","article-title":"Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase","volume":"101","author":"Gustafsson","year":"2007","journal-title":"Circ Res"},{"key":"R45-20230917","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/ATVBAHA.108.173344","article-title":"Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression","volume":"28","author":"Devlin","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R47-20230917","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(02)03731-6","article-title":"The physical state of the LDL core influences the conformation of apolipoprotein B-100 on the lipoprotein surface","volume":"533","author":"Coronado-Gray","year":"2003","journal-title":"FEBS Lett"},{"key":"R48-20230917","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1194\/jlr.M039644","article-title":"LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis","volume":"54","author":"Melchior","year":"2013","journal-title":"J Lipid Res"},{"key":"R49-20230917","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.ATV.0000117174.19078.85","article-title":"Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100","volume":"24","author":"Flood","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R50-20230917","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1161\/ATVBAHA.115.305614","article-title":"Kinetic and related determinants of plasma triglyceride concentration in abdominal obesity: multicenter tracer kinetic study","volume":"35","author":"Bor\u00e9n","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R51-20230917","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1194\/jlr.M200322-JLR200","article-title":"ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan","volume":"43","author":"Olin-Lewis","year":"2002","journal-title":"J Lipid Res"},{"key":"R52-20230917","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1194\/jlr.M500161-JLR200","article-title":"A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes","volume":"46","author":"Davidsson","year":"2005","journal-title":"J Lipid Res"},{"key":"R53-20230917","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.2337\/db09-0206","article-title":"ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan","volume":"58","author":"Hiukka","year":"2009","journal-title":"Diabetes"},{"key":"R54-20230917","doi-asserted-by":"crossref","first-page":"19341","DOI":"10.1074\/jbc.C112.350785","article-title":"Novel role of ADAMTS-5 in proteoglycan turnover and lipoprotein retention in atherosclerosis","volume":"287","author":"Didangelos","year":"2012","journal-title":"J Biol Chem"},{"key":"R55-20230917","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/ATVBAHA.108.176800","article-title":"Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican","volume":"28","author":"Seidelmann","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R56-20230917","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.yjmcc.2014.07.014","article-title":"Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection","volume":"75","author":"Tang","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"R57-20230917","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/cvr\/cvn099","article-title":"Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans","volume":"79","author":"Nakashima","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R58-20230917","doi-asserted-by":"crossref","first-page":"e0137311","DOI":"10.1371\/journal.pone.0137311","article-title":"The NG2 proteoglycan protects oligodendrocyte precursor cells against oxidative stress via interaction with OMI\/HtrA2","volume":"10","author":"Maus","year":"2015","journal-title":"PLoS One"},{"key":"R59-20230917","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.jcbfm.9600519","article-title":"Accumulation of macrophage-like cells expressing NG2 proteoglycan and Iba1 in ischemic core of rat brain after transient middle cerebral artery occlusion","volume":"28","author":"Matsumoto","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"R60-20230917","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/cvr\/cvt044","article-title":"Does low and oscillatory wall shear stress correlate spatially with early atherosclerosis? A systematic review","volume":"99","author":"Peiffer","year":"2013","journal-title":"Cardiovasc Res"},{"key":"R61-20230917","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1093\/eurheartj\/ehu353","article-title":"Biomechanical factors in atherosclerosis: mechanisms and clinical implications","volume":"35","author":"Kwak","year":"2014","journal-title":"Eur Heart J"},{"key":"R62-20230917","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/ATVBAHA.115.305874","article-title":"Disturbed laminar blood flow vastly augments lipoprotein retention in the artery wall: a key mechanism distinguishing susceptible from resistant sites","volume":"35","author":"Steffensen","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R63-20230917","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1161\/ATVBAHA.112.300444","article-title":"Induction of antianti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"32","author":"Brito","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R64-20230917","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.freeradbiomed.2015.08.027","article-title":"Arresting progressive atherosclerosis by immunization with an antiglycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice","volume":"89","author":"Delgado-Roche","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"R65-20230917","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.106.2748.190","article-title":"Atherosclerosis and alimentary hyperlipemia","volume":"106","author":"Moreton","year":"1947","journal-title":"Science"},{"key":"R66-20230917","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","article-title":"Atherogenesis: a postprandial phenomenon","volume":"60","author":"Zilversmit","year":"1979","journal-title":"Circulation"},{"key":"R67-20230917","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.atherosclerosis.2016.02.004","article-title":"Imbalanced insulin action in chronic over nutrition: clinical harm, molecular mechanisms, and a way forward","volume":"247","author":"Williams","year":"2016","journal-title":"Atherosclerosis"},{"key":"R68-20230917","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","volume":"239","author":"Taskinen","year":"2015","journal-title":"Atherosclerosis"},{"key":"R69-20230917","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MOL.0b013e328338cabc","article-title":"Recent insights into factors affecting remnant lipoprotein uptake","volume":"21","author":"Williams","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"R70-20230917","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R71-20230917","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"R72-20230917","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.25580","article-title":"Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemia","volume":"55","author":"Hassing","year":"2012","journal-title":"Hepatology"},{"key":"R73-20230917","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1316222","article-title":"A 52-week placebo-controlled trial of evolocumab in hyperlipidemia","volume":"370","author":"Blom","year":"2014","journal-title":"N Engl J Med"},{"issue":"(suppl. 1)","key":"R74-20230917","first-page":"A68","article-title":"Evaluation of the glycemic effects and efficacy and safety of evolocumab (AMG 145) in subjects with or without dysglycemia or metabolic syndrome","volume":"64","author":"Holman","year":"2015","journal-title":"Diabetes"},{"key":"R75-20230917","doi-asserted-by":"crossref","first-page":"20419","DOI":"10.1016\/S0021-9258(20)80745-5","article-title":"Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation","volume":"268","author":"Tabas","year":"1993","journal-title":"J Biol Chem"},{"key":"R76-20230917","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"R77-20230917","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa070635","article-title":"Effect of torcetrapib on the progression of coronary atherosclerosis","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"R78-20230917","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1194\/jlr.R050252","article-title":"Acidification of the intimal fluid: the perfect storm for atherogenesis","volume":"56","author":"\u00d6\u00f6rni","year":"2015","journal-title":"J Lipid Res"},{"key":"R79-20230917","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1194\/jlr.M023218","article-title":"Conformational changes of apoB-100 in SMase-modified LDL mediate formation of large aggregates at acidic pH","volume":"53","author":"Sneck","year":"2012","journal-title":"J Lipid Res"},{"key":"R80-20230917","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/9781118828533.ch24","article-title":"Apolipoprotein-B: the crucial protein of atherogenic lipoproteins","author":"Williams","year":"2015","journal-title":"Atherosclerosis: risks, mechanisms, & therapies"},{"key":"R81-20230917","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/BSR20120036","article-title":"Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr \u2212\/\u2212 mice fed on a high-fat diet","volume":"32","author":"Deevska","year":"2012","journal-title":"Biosci Rep"},{"key":"R82-20230917","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"key":"R83-20230917","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MOL.0000000000000219","article-title":"Endothelial and smooth muscle cell transformation in atherosclerosis","volume":"26","author":"Lao","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"R84-20230917","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R85-20230917","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ncpcardio1086","article-title":"Rapid regression of atherosclerosis: insights from the clinical and experimental literature","volume":"5","author":"Williams","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"(Suppl 1)","key":"R86-20230917","doi-asserted-by":"crossref","first-page":"55.9","DOI":"10.4049\/jimmunol.190.Supp.55.9","article-title":"Induction of neural guidance molecule expression in macrophages and dendritic cells by Mycobacterium tuberculosis","volume":"190","author":"Bracho-Sanchez","year":"2013","journal-title":"J Immunol"},{"key":"R87-20230917","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2012.06.023","article-title":"What does HDL do? A new mechanism to slow atherogenesis \u2013 but a new problem in type 2 diabetes mellitus","volume":"225","author":"Williams","year":"2012","journal-title":"Atherosclerosis"},{"key":"R88-20230917","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/CIRCRESAHA.112.280958","article-title":"HDL and cardiovascular risk: time to call the plumber?","volume":"111","author":"Hewing","year":"2012","journal-title":"Circ Res"},{"key":"R89-20230917","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"R90-20230917","first-page":"504","article-title":"Influence of serum high density lipoprotein on the low density lipoprotein-aortic glycosaminoglycan interactions","volume":"4","author":"Bihari-Varga","year":"1978","journal-title":"Artery"},{"key":"R91-20230917","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.0954-6820.1980.tb10948.x","article-title":"Factors modulating the interaction of LDL with an arterial lipoprotein complexing proteoglycan: the effect of HDL","volume":"642","author":"Camejo","year":"1980","journal-title":"Acta Med Scand Suppl"},{"key":"R92-20230917","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.atherosclerosis.2012.08.040","article-title":"HDL2 interferes with LDL association with arterial proteoglycans: a possible athero-protective effect","volume":"225","author":"Umaerus","year":"2012","journal-title":"Atherosclerosis"},{"key":"R93-20230917","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1172\/JCI118934","article-title":"Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins","volume":"98","author":"Schissel","year":"1996","journal-title":"J Clin Invest"},{"key":"R94-20230917","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"De Nardo","year":"2014","journal-title":"Nat Immunol"},{"key":"R95-20230917","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cmet.2014.01.009","article-title":"High-density lipoproteins put out the fire","volume":"19","author":"Moore","year":"2014","journal-title":"Cell Metab"},{"key":"R96-20230917","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/ATVBAHA.113.303044","article-title":"Effects of native and myeloperoxidase-modified apolipoprotein A-I on reverse cholesterol transport and atherosclerosis in mice","volume":"34","author":"Hewing","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R97-20230917","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4049\/jimmunol.1403044","article-title":"Reconstituted high-density lipoprotein attenuates cholesterol crystal-induced inflammatory responses by reducing complement activation","volume":"195","author":"Niyonzima","year":"2015","journal-title":"J Immunol"},{"key":"R98-20230917","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/ATVBAHA.110.211342","article-title":"High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo","volume":"30","author":"Bursill","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R99-20230917","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1194\/jlr.M059485","article-title":"Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation","volume":"56","author":"Nguyen","year":"2015","journal-title":"J Lipid Res"},{"key":"R100-20230917","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/ATVBAHA.111.226159","article-title":"Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans","volume":"31","author":"Chiba","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R101-20230917","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nm.3459","article-title":"An abundant dysfunctional apolipoprotein A1 in human atheroma","volume":"20","author":"Huang","year":"2014","journal-title":"Nat Med"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201610000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T15:57:46Z","timestamp":1718726266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201610000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000330","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726628394.793528325","asserted-by":"object"}]},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}